A Phase 1 Study of IMGN289 in Adult Patients With EGFR-positive Solid Tumors

This study is currently recruiting participants. (see Contacts and Locations)
Verified January 2014 by ImmunoGen, Inc.
Sponsor:
Information provided by (Responsible Party):
ImmunoGen, Inc.
ClinicalTrials.gov Identifier:
NCT01963715
First received: October 9, 2013
Last updated: February 27, 2014
Last verified: January 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: June 2017 (Final data collection date for primary outcome measure)